Ubs Group Ag Scopus Bio Pharma Inc. Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.23 - $0.45 $495 - $969	2,154 Added 2154.0%	2,254 $1,000
Q1 2022 May 16, 2022	SELL	$0.6 - $1.7 $2,844 - $8,058	-4,740 Reduced 97.93%	100 $0
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $7,726 - $20,287	4,740 Added 4740.0%	4,840 $8,000
Q3 2021 Nov 15, 2021	SELL	$4.0 - $6.99 $21,420 - $37,431	-5,355 Reduced 98.17%	100 $0
Q2 2021 Aug 13, 2021	BUY	$5.17 - $10.25 $13,669 - $27,101	2,644 Added 94.06%	5,455 $39,000
Q1 2021 May 12, 2021	BUY	$7.94 - $14.87 $22,319 - $41,799	2,811 New	2,811 $24,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.